Cipla Recalls over 1.4 lakh Vials of Asthma Drug in US

Drug major Cipla is recalling in the US market 1,40,625 vials of Levalbuterol Inhalation Solution used for relieving shortness of breath and coughing caused by asthma and chronic obstructive pulmonary disease. As per the information available on the USFDA website, Cipla is recalling the drug for "failed impurities and degradation specifications". The vials were manufactured by Cipla at its Pithampur manufacturing facility, near Ind...